Managing Weight With Wegovy®

If you're struggling with weight loss, you're not alone. Learn how Wegovy®, along with a reduced calorie diet and increased physical activity, can help adults with obesity or overweight with weight-related medical problems lose weight and keep it off.

A medium-light skin toned, feminine-presenting person in their thirties painting in an outdoor area. Actor portrayals.

Losing weight with Wegovy®*

Weight loss with Wegovy® has been measured in several medical studies. Take a look at the results from one of the studies that lasted about 1 year and 4 months (68 weeks).

The study included

Adults with either obesity or overweight with a weight-related medical condition

Adults were randomly placed into 2 groups

Everyone was instructed to follow a reduced-calorie diet and increase their physical activity.

The results showed

Adults taking Wegovy® lost more weight than those taking placebo.

Adults who took Wegovy® achieved on average 15% weight loss

~232 lb starting weight

Adults who took placebo achieved on average ~2.5% weight loss

~232 lb starting weight

What else did the results show?

Everyone is different, but let's dig deeper into the data to get some insight.

83% or about 8 in 10 adults achieved

5% or more weight loss with Wegovy®

compared with 31% taking placebo

66% or about 6 in 10 adults achieved

10% or more weight loss with Wegovy®

compared with 12% taking placebo

48% or about half of adults achieved

15% or more weight loss with Wegovy®

compared with 5% taking placebo

And that’s not all—some adults lost even more weight

About 1 in 3 adults achieved 20% weight loss

based on ~232 lb starting weight

30% of adults (about 1 in 3) taking Wegovy® lost 20% or more weight compared with 2% of adults on placebo. This result was not the primary goal of the study and should be considered as additional information.

Individual results may vary.

*Results are from a 68-week medical study of adults with either obesity (BMI ≥ 30) and adults with overweight (BMI ≥ 27) who also had weight-related medical problems, including high blood pressure or high cholesterol. Adults with type 2 diabetes were excluded. During the trial, 17% of adults in the Wegovy® group discontinued treatment compared with 22% of adults in the placebo group.

Discover your potential weight loss with Wegovy®†

Wondering what the study results discussed above might look like for you? See how much weight you could lose while taking Wegovy® along with a reduced calorie diet and increased physical activity.

weightloss-time

Enter your weight


Individual results may vary.

-10lb

–If you lose 5% of your current weight

-20lb

–If you lose 10% of your current weight

-30lb

–If you lose 15% of your current weight

-40lb

–If you lose 20% of your current weight

Your potential weight loss results are based on the study explained above.

Why 5%? In the study discussed above, 83% of adults taking Wegovy® lost 5% or more body weight, compared with 31% of adults taking placebo.

Why 10%? In the study discussed above, 66% of adults taking Wegovy® lost 10% or more body weight, compared with 12% of adults taking placebo.

Why 15%? In the study discussed above, adults on average achieved 15% weight loss while taking Wegovy®, compared with 5% of adults taking placebo.

Why 20%? In a supportive measure of the same study discussed above, ~30% of adults taking Wegovy® lost 20% or more weight compared with ~2% of adults taking placebo.

Talk to your health care professional about a goal weight that is healthy & realistic for you.

Health care professionals prescribe Wegovy® to help with losing weight and keeping it off in adults living with obesity and some with overweight and weight-related medical problems.

Benefits beyond the scale

While not approved to treat these conditions, adults taking Wegovy® experienced improvements in:

Waist size 

Blood pressure

Cholesterol

Blood sugar

Some adults taking Wegovy® experienced an increase in resting heart rate.

Results are from a 68-week medical study of adults with either obesity (BMI ≥ 30) and adults with overweight (BMI ≥ 27) who also had weight-related medical problems, including high blood pressure or high cholesterol. Adults with type 2 diabetes were excluded. Both groups received instruction for a reduced calorie diet and increased physical activity.

Keeping the weight off with Wegovy®

Take a look at 2 more studies. One study measured weight change when adults taking Wegovy® either stayed on Wegovy® or switched to placebo.§ Another study followed weight maintenance in adults taking Wegovy® over the course of 2 years.

Why stay on Wegovy®?§

In a medical study that lasted about 1 year and 4 months (68 weeks), everyone took Wegovy® for the first 5 months (20 weeks) while also reducing calories and increasing physical activity.

At month 5 (week 20), adults were divided into 2 groups: One group continued taking Wegovy®, while the other group switched to placebo.

From month 5 through the end of the study, adults who stayed on Wegovy® continued to lose weight, while the adults taking placebo gained weight.

§This medical study included 902 adults with either obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with at least 1 weight-related condition. Adults with type 2 diabetes were excluded. In the first 20 weeks, everyone started taking Wegovy®. Of these 902 adults, 803 were able to reach the 2.4-mg dose and were randomized to stay on Wegovy® (535 adults) or switch to placebo (268 adults). After week 20, 5.8% of participants taking Wegovy® discontinued treatment compared with the 11.6% taking placebo. Adults who continued taking Wegovy® lost an additional 7.9% of their body weight on average while those who switched to placebo gained 6.9% body weight on average. Everyone was instructed to follow a reduced calorie diet and increase their physical activity throughout the length of the study.

Adults taking Wegovy® achieved lasting weight loss in a separate
2-year medical study

Proven to maintain weight loss

  • On average, adults taking Wegovy® lost ~15% of their body weight (~35 lb) vs 2.6% (~6 lb) for adults taking placebo
  • The majority of adults taking Wegovy® (77%) lost 5% or more weight compared with 34% taking placebo
  • Average starting weight for adults taking Wegovy® was ~233 lb, and for those taking placebo, it was ~235 lb

This 2-year medical study included 304 adults with either obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with at least 1 weight-related medical condition. Adults with diabetes were excluded. Everyone received instruction for a reduced calorie diet and increased physical activity. During the trial, 13% of participants taking Wegovy® discontinued treatment compared with 27% taking placebo.

In general, those who stopped taking Wegovy® regained weight

Explore the science behind Wegovy® 

Get a better understanding of how Wegovy® helps people lose weight and keep it off.

Learn how it works

Not sure how to discuss Wegovy® with your health care professional?

Get the conversation guide

Ready to learn more about Wegovy®? We can help.

Get personalized emails with information, guidance, and timely tips to help you feel more confident taking the next step.

Sign up for Wegovy® emails

Next:

Get answers to some FAQs

Call 1-833-4-WEGOVY (1-833-493-4689) between 9:00 AM and 9:00 PM ET, Monday–Friday.

CALL NOW
Continue

You are now leaving Wegovy.com and going to a Novo Nordisk US
affiliated site.

Continue